Skip to main content
Clinical Trials/NCT00371891
NCT00371891
Completed
Phase 4

The Ontario Multidetector Computed Tomography (MDCT) Coronary Angiography Study (OMCAS)

St. Joseph's Healthcare Hamilton4 sites in 1 country168 target enrollmentSeptember 2006

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Coronary Arteriosclerosis
Sponsor
St. Joseph's Healthcare Hamilton
Enrollment
168
Locations
4
Primary Endpoint
Sensitivity and specificity of MDCTCA as compared to CICA
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

Multidetector Computed Tomographic Coronary Angiography (MDCTCA) has been recently demonstrated to be accurate and may be used as a potential alternative to conventional invasive coronary angiography, which requires cardiac catheterization, for the diagnosis of coronary artery disease. The purpose of this study is to see if MDCTCA can identify significant coronary artery disease as good as or better than conventional coronary angiography (CICA). The study is designed to enroll 900 subjects and is being conducted in 6 hospitals in Ontario. Subjects scheduled for conventional cardiac catheterization and coronary angiography will receive an additional test using MDCTCA. The information gathered during the MDCTCA will be compared to the results of the scheduled conventional invasive coronary angiogram.

Registry
clinicaltrials.gov
Start Date
September 2006
End Date
June 2009
Last Updated
15 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Valvular heart disease (mitral stenosis, mitral regurgitation, aortic stenosis or aortic insufficiency) or
  • Congenital heart disease (i.e. VSD, ASD, PDA) or
  • Cardiomyopathy OR
  • Intermediate probability of coronary artery disease (probability of 10-90%) after clinical evaluation and traditional non-invasive testing

Exclusion Criteria

  • Age \< 18 years
  • Lack of consent
  • Renal Insufficiency (GFR \< 60 mL/min)
  • Allergy to contrast agent
  • Refractory angina requiring urgent/emergent coronary angiography (as per treating physician)
  • Pregnancy or breast feeding
  • Uncontrolled heart rate
  • Previous CABG or PCI/Stent
  • Chronic atrial fibrillation
  • History of acute myocardial infarction, as defined by a creatine kinase (CK) level greater than 2 times normal with a troponin level above

Outcomes

Primary Outcomes

Sensitivity and specificity of MDCTCA as compared to CICA

Time Frame: After both MDCTCA and CICA are completed

Secondary Outcomes

  • Descriptive statistics (rates and proportions) will be calculated for the number of "avoidable" diagnostic cardiac catheterizations.(After both MDCTCA and CICA are completed)
  • The accuracy of MDCTCA to CICA will be compared in categorizing patients inot single, double, triple vessel, left main disease or no coronary stenosis.(After both MDCTCA and CICA are completed)
  • The accuracy of MDCTCA to eliminate correctly the need for CICA will be calculated.(After both MDCTCA and CICA are completed)

Study Sites (4)

Loading locations...

Similar Trials